Search Ontology:
ChEBI
bromocriptine
- Term ID
- CHEBI:3181
- Synonyms
-
- (5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman
- (5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione
- (5'alpha)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-2'-(propan-2-yl)-3',6',18-trioxoergotaman
- (5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman
- 2-bromo-alpha-ergocryptine
- 2-bromo-alpha-ergokryptin
- 2-bromo-alpha-ergokryptine
- bromocriptine
- bromocriptinum
- bromocryptine
- bromoergocriptine
- Definition
- References
-
- Beilstein:741357
- CAS:25614-03-3
- DrugBank:DB01200
- Drug_Central:403
- KEGG:C06856
- KEGG:D03165
- LINCS:LSM-6550
- Patent:DE1926045
- Patent:US3752814
- Wikipedia:Bromocriptine
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
- is a type of
-
- has_parent_hydride
-
- has_role
-
- inverse has_part
-
Phenotype
Phenotype resulting from bromocriptine
Phenotype where environments contain bromocriptine
Phenotype modified by environments containing bromocriptine
Human Disease Model